Matthew Henn

Chief Tech/Sci/R&D Officer presso SERES THERAPEUTICS, INC.

Patrimonio netto: 49 099 $ in data 31/03/2024

49 anni

Consumer Services

Health Technology

Posizioni attive di Matthew Henn

Società	Posizione	Inizio	Fine
SERES THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	07/02/2019	-
SERES THERAPEUTICS, INC.	Corporate Officer/Principal	01/06/2012	07/02/2019

Società	Posizione	Inizio	Fine
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/03/2005	01/06/2012
Viral Genomics, Inc.	Director/Board Member	-	-

University of California, Berkeley	Doctorate Degree
University of New Hampshire	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
Doctorate Degree	1
Chief Tech/Sci/R&D Officer	1

Settori

Consumer Services	3
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
SERES THERAPEUTICS, INC.	Health Technology

Aziende private	2
Viral Genomics, Inc.
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Viral Genomics, Inc.

Health Technology